| Application no. and date | 14861625.3 (espacenet) (Federated) (European Patent Register), 20141112 | | Patent/reg. no. and date | DK/EP 3068411, 20200318 | | Publication date | 20160921 | | Priority no. and date | US 201361904783 P, 20131115 | | EP pub. no. and date |
EP 3068411 20160921 | | Effective date | | | Applicant/owner | Oncolytics Biotech Inc., Suite 210
1167 Kensington Crescent N. W.
Calgary, AB T2N 1X7, CA | | Applicant ref. no. | P024023EPDK1 JOS/GB | | Inventor | COFFEY, Matthew C., 2231 Bowness Road NW
Calgary, Alberta T2N 3L4, CA,
THOMPSON, Bradley G., 1775 7th Avenue NW
Calgary, Alberta T2N 0Z5, CA | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/555 (2006.01) , A61K 35/76 (2015.01) , A61K 35/765 (2015.01) , A61K 35/768 (2015.01) , A61P 35/00 (2006.01) | | Title | Oncolytiske vira og forøget cancerbehandlingsregimer | | Int. application no. | CA2014000806 | | Int. publication no. | WO2015070323 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
